A new UCLA clinical trial may allow transplant recipients to stop taking daily immunosuppressive medications, reducing side effects and improving long-term health. PKD Foundation Center of Excellence Director Heedok Han, M.D. (Columbia University Irving Medical Center) shares what this could mean for patients.
“The possibility that some patients might one day need fewer immunosuppressive medications, or potentially come off them entirely, is something we have long wished for. This approach is still in the experimental stage, but it points toward meaningful progress. As someone who cares for many patients living with PKD, I’m very excited by this work and optimistic about where continued research may lead.”
Innovation like this could dramatically improve the quality of life for kidney transplant patients.
Related Resources
- Advocacy
- Clinical Trials
- Conference
- Drug Therapy and Treatments
- PKD News
- Research
- TKV
- Total kidney volume
- ADPKD
- Centers of Excellence
- Education
- Healthcare Team
- Nephrologist
- PKD News
- PKD Parents
- Research